Cis-aconitate Decarboxylase Mutants for Itaconic Acid Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing itaconic acid, a crucial compound in the chemical industry, are limited by the enzymatic activity of wild-type cis-aconitate decarboxylase (CAD) in microorganisms like Aspergillus terreus, which restricts the yield and efficiency of its biosynthesis.

Innovation Solution

Genetically modified Aspergillus strains with CAD mutants carrying mutations in the C-terminal region, specifically in the 441-490 amino acid sequence, exhibit enhanced enzymatic activity, leading to higher itaconic acid production. These mutants are engineered to increase the production levels by introducing specific mutations such as substitutions at positions 489 and 490, and are expressed in host cells for optimal production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If wild-type CAD is used in Aspergillus terreus, then the microorganism can produce itaconic acid, but the enzymatic activity is insufficient to achieve high yield

Engineering Contradiction:
Improveitaconic acid production yieldVSAvoidenzymatic activity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by introducing specific amino acid mutations at positions 489 and 490 in the C-terminal region of CAD protein. These mutations alter the enzymatic parameters of the protein, specifically increasing its catalytic activity towards cis-aconitate decarboxylation, thereby achieving higher itaconic acid production yield while maintaining protein functionality

Inventive Principle:
Principle #35Parameter changes

2Reliability

If CAD mutations are introduced to enhance enzymatic activity, then itaconic acid production increases, but the protein sequence deviates from wild-type

Engineering Contradiction:
Improveenzymatic activityVSAvoidprotein sequence consistency
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies local quality by making targeted mutations only at specific positions (489 and 490) in the C-terminal region of the CAD protein, while leaving the rest of the protein sequence unchanged. This localized modification approach enhances enzymatic activity at the active site without compromising the overall structural stability and functional integrity of the protein

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The CAD mutants demonstrate significantly increased enzymatic activity and itaconic acid production compared to wild-type CAD, resulting in higher yields and improved biosynthesis efficiency.

Implementation Method 1

cis-aconitate decarboxylase (CAD) plays the key role in the biosynthesis of this compound

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

CAD, which converts cis-aconitic acid to itaconic acid

Methodology Applied
Scientific EffectDecarboxylation reaction: Chemical Bonding

Data Source

PatentUS8338158B2Cis-aconitate decarboxylase mutants having improved enzymatic activity
Publication Date: 2012.12.25 IND TECH RES INST
  • US8338158B2 patent drawing
  • US8338158B2 patent drawing
  • US8338158B2 patent drawing

AI summary

Cis-aconitate decarboxylase mutants having one or more mutations in a C-terminal region as compared with a wild-type cis-aconitate decarboxylase of Aspergillus terreus.